Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details.
BohanAPeterJB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344-347.MarguerieCBunnCCBeynonHLC. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med. 1990;77(282):1019-1038.FriedmanAWTargoffINArnettFC. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum. 1996;26(1):459-467.BrouwerRHengstmanGJDVree EgbertsW. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis. 2001;60(2):116-123.WilkesMSereikaSFertigN. Treatment of antisynthetase associated interstitial lung disease with tacrolimus in patients with idiopathic inflammatory myopathy. Arthritis Rheum. 2003;48supplS434.FathiMVikgrenJBoijsenM. Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum. 2008;59(5):677-685.KalluriMSahnSAOddisCV. Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature. Chest. 2009;135(6):1550-1556.ConnorsGRChristopher-StineLOddisCVDanoffSK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?Chest. 2010;138(6):1464-1474.LabiruaALundbergIE. Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Curr Opin Rheumatol. 2010;22(6):633-638.